Plasma sphingosine 1-phosphate metabolism and analysis.
暂无分享,去创建一个
[1] A. Kihara,et al. The immunomodulator FTY720 is phosphorylated and released from platelets. , 2007, European journal of pharmacology.
[2] Y. Yatomi,et al. Fluid shear stress enhances the sphingosine 1-phosphate responses in cell-cell interactions between platelets and endothelial cells. , 2007, Biochemical and biophysical research communications.
[3] M. Tani,et al. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. , 2007, Biochemical and biophysical research communications.
[4] J. Cyster,et al. Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.
[5] M. Gräler,et al. Erythrocytes store and release sphingosine 1‐phosphate in blood , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] S. Milstien,et al. Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives* , 2007, Journal of Biological Chemistry.
[7] T. Ishizuka,et al. Role of Scavenger Receptor Class B Type I and Sphingosine 1-Phosphate Receptors in High Density Lipoprotein-induced Inhibition of Adhesion Molecule Expression in Endothelial Cells* , 2006, Journal of Biological Chemistry.
[8] Yutong Zhao,et al. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. , 2006, Cellular signalling.
[9] A. Yamaguchi,et al. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner Published, JLR Papers in Press, December 21, 2005. , 2006, Journal of Lipid Research.
[10] H. Matsuyuki,et al. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. , 2006, Cellular & molecular immunology.
[11] Y. Yatomi,et al. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. , 2006, Current pharmaceutical design.
[12] Hugh Rosen,et al. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. , 2006, Current pharmaceutical design.
[13] H. Ikeda,et al. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. , 2005, Clinical biochemistry.
[14] R. Koopmans,et al. A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] Y. Yatomi,et al. Sphingosine 1-phosphate-related metabolism in the blood vessel. , 2005, Journal of biochemistry.
[16] V. Natarajan,et al. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. , 2005, Analytical biochemistry.
[17] T. Hla. Physiological and pathological actions of sphingosine 1-phosphate. , 2004, Seminars in cell & developmental biology.
[18] S. Yamamura,et al. Sphingosine 1-phosphate breakdown in platelets. , 2004, Journal of biochemistry.
[19] S. Pyne,et al. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. , 2004, Seminars in cell & developmental biology.
[20] J. Cyster,et al. FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] R. Proia,et al. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. , 2003, Blood.
[22] Sarah Spiegel,et al. Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.
[23] T. Ohmori,et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. , 2003, Cardiovascular research.
[24] K. Fukuzawa,et al. Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.
[25] G. Mills,et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.
[26] M. Macey,et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.
[27] F. Okajima. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? , 2002, Biochimica et biophysica acta.
[28] D. Brindley,et al. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. , 2002, Biochimica et biophysica acta.
[29] Y. Takuwa. Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. , 2002, Biochimica et biophysica acta.
[30] T. Hla,et al. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. , 2002, Biochimica et biophysica acta.
[31] S. Chae,et al. Extracellular Export of Sphingosine Kinase-1 Enzyme , 2002, The Journal of Biological Chemistry.
[32] M. Ui,et al. Sphingosine 1-Phosphate May Be a Major Component of Plasma Lipoproteins Responsible for the Cytoprotective Actions in Human Umbilical Vein Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[33] T. Ohmori,et al. Sphingosine 1-phosphate: synthesis and release. , 2001, Prostaglandins & other lipid mediators.
[34] M. Schäfer-Korting,et al. An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.
[35] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[36] H. Flad,et al. Platelet‐derived CXC chemokines: old players in new games , 2000, Immunological reviews.
[37] Koichi Sato,et al. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. , 2000, Analytical biochemistry.
[38] A. Merrill,et al. A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples. , 2000, Analytical biochemistry.
[39] Y. Yatomi,et al. Metabolism and functional effects of sphingolipids in blood cells , 1999, British journal of haematology.
[40] K. Claffey,et al. Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.
[41] C. H. Liu,et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.
[42] C. O'neill,et al. Studies of the Nature of the Binding by Albumin of Platelet-activating Factor Released from Cells* , 1997, The Journal of Biological Chemistry.
[43] Y. Igarashi,et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.
[44] Y. Igarashi,et al. Sphingosine 1-Phosphate Induces Platelet Activation through an Extracellular Action and Shares a Platelet Surface Receptor with Lysophosphatidic Acid* , 1997, The Journal of Biological Chemistry.
[45] Y. Oda,et al. Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry. , 1997, Analytical biochemistry.
[46] D. V. Lynch,et al. Characterization of sphinganine kinase activity in corn shoot microsomes. , 1997, Archives of biochemistry and biophysics.
[47] S. Hakomori,et al. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride. , 1995, Analytical biochemistry.
[48] D. Bratton. Release of platelet activation factor from activated neutrophils. Transglutaminase-dependent enhancement of transbilayer movement across the plasma membrane. , 1993, The Journal of biological chemistry.